Abstract:Importance: Machine-learning algorithms offer better predictive accuracy than traditional prognostic models but are too complex and opaque for clinical use.Objective: To compare different machine learning methods in predicting overall mortality in cirrhosis and to use machine learning to select easily scored clinical variables for a novel cirrhosis prognostic model.Design, Setting, and Participants: This prognostic study used a retrospective cohort of adult patients with cirrhosis or its complications seen in 130 hospitals and affiliated ambulatory clinics in the integrated, national Veterans Affairs health care system from October 1, 2011, to September 30, 2015. Patients were followed up through December 31, 2018. Data were analyzed from October 1, 2017, to May 31, 2020.Exposures: Potential predictors included demographic characteristics; liver disease etiology, severity, and complications; use of health care resources; comorbid conditions; and comprehensive laboratory and medication data. Patients were randomly selected for model development (66.7%) and validation (33.3%). Three different statistical and machine learning methods were evaluated: gradient descent boosting, logistic regression with least absolute shrinkage and selection operator (LASSO) regularization, and logistic regression with LASSO constrained to select no more than 10 predictors (partial pathway model). Predictor inclusion and model performance were evaluated in a 5-fold cross-validation. Last, the predictors identified in the most parsimonious (the partial path) model were refit using maximum-likelihood estimation (Cirrhosis Mortality Model [CiMM]), and its predictive performance was compared with that of the widely used Model for End Stage Liver Disease with sodium (MELD-Na) score.Main Outcomes and Measures: All-cause mortality.Results: Of the 107 939 patients with cirrhosis (mean [SD] age, 62.7 [9.6] years; 96.6% male; 66.3% white, 18.4% African American), the annual mortality rate ranged from 8.8% to 15.3%. In total, 32.7% of patients died within 3 years, and 46.2% died within 5 years after the index date. Models predicting 1-year mortality had good discrimination for the gradient descent boosting (area under the receiver operating characteristics curve [AUC], 0.81; 95% CI, 0.80-0.82), logistic regression with LASSO regularization (AUC, 0.78; 95% CI, 0.77-0.79), and the partial path logistic model (AUC, 0.78; 95% CI, 0.76-0.78). All models showed good calibration. The final CiMM model with machine learning-derived clinical variables offered significantly better discrimination than the MELD-Na score, with AUCs of 0.78 (95% CI, 0.77-0.79) vs 0.67 (95% CI, 0.66-0.68) for 1-year mortality, respectively (DeLong z = 17.00; P < .001).Conclusions and Relevance: In this study, simple machine learning techniques performed as well as the more advanced ensemble gradient boosting. Using the clinical variables identified from simple machine learning in a cirrhosis mortality model produced a new score more transparent than machine learning and more predictive than the MELD-Na score.

Development and validation of an explainable machine learning model for predicting multidimensional frailty in hospitalized patients with cirrhosis

Development and Validation of Risk Prediction Model for Identifying 30-Day Frailty in Older Inpatients with Undernutrition: A Multicenter Cohort Study.

The application of machine learning for identifying frailty in older patients during hospital admission

Developing and validating machine learning-based prediction models for frailty occurrence in those with chronic obstructive pulmonary disease

Physical frailty identification using machine learning to explore the 5-item FRAIL scale, Cardiovascular Health Study index, and Study of Osteoporotic Fractures index

Development and Validation of a Risk Prediction Model for Frailty in Patients with Chronic Diseases

A Multifactor Model for Predicting Mortality in Critically Ill Patients: A Multicenter Prospective Cohort Study

Development and validation of frailty risk prediction model for elderly patients with coronary heart disease

Explainable artificial intelligence model for mortality risk prediction in the intensive care unit: a derivation and validation study

A self-reported Frailty Index predicts long-term mortality in hospitalized patients with cirrhosis

Advancing non-alcoholic fatty liver disease prediction: a comprehensive machine learning approach integrating SHAP interpretability and multi-cohort validation

Development and Validation of Prediction Models for Incident Reversible Cognitive Frailty Based on Social-Ecological Predictors Using Generalized Linear Mixed Model and Machine Learning Algorithms: A Prospective Cohort Study

Interpretable Machine Learning Models Using Peripheral Immune Cells to Predict 90-Day Readmission or Mortality in Acute Heart Failure Patients

Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality

Predicting the 28-day prognosis of acute-on-chronic liver failure patients based on machine learning

Machine learning-based model for worsening heart failure risk in Chinese chronic heart failure patients

Enhancing the convenience of frailty index assessment for elderly Chinese people with machine learning methods

Explainable machine learning to predict long-term mortality in critically ill ventilated patients: a retrospective study in central Taiwan

Development and Validation of a Clinical Support System for Predicting Incident Frailty among Community-Dwelling Older Adults: A Prospective Cohort Study

Interpretable machine learning model for predicting long-term cardiovascular mortality risk in chronic kidney disease patients using SHAP explainers

Machine Learning Models for Predicting Mortality in Patients with Cirrhosis and Acute Upper Gastrointestinal Bleeding at an Emergency Department: A Retrospective Cohort Study